Epstein-Barr Virus Latency and Activation in Vivo

  • I. Ernberg
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 166)


Epstein-Barr virus (EBV) infects most human beings in childhood or adolescence. Lifelong latency is established after primary infection.


Burkitt Lymphoma Lymphoblastoid Cell Line Infectious Mononucleosis Virus Gene Expression Lytic Cycle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andersson J, Sköldenberg B, Ernberg I, Britton S, Henle W, Andersson U (1985) Acyclovir treatment in primary Epstein-Barr virus infection. A double blind placebo controlled study Scand J Inf Dis, supplement 47:107–115Google Scholar
  2. Anderssson J, Britton S, Ernberg I, Andersson U, Henle W, Sköldenberg B, Tisell A (1986) Effect of acyclovir on infectious mononucleosis. A double-blind, placebo-controlled study J Inf Dis 153:283–290CrossRefGoogle Scholar
  3. Andersson J, Sköldenberg B, Henle W, Britton S, Ernberg I (1987) Peroral acyclovir treatment in infectious mononucleosis Infection 15:14–21CrossRefGoogle Scholar
  4. Chang RS (1980) Infectious mononucleosis GK Hall Medical Publishers Boston p 130Google Scholar
  5. Ernberg I, Masucci G, Klein G (1976) Persistence of Epstein-Barr virus nuclea antigen (EBNA) in cells entering EB viral cycle Int J Cancer 17:197–203CrossRefGoogle Scholar
  6. Ernberg I, Andersson J (1986) Acyclovir efficiently inhibits oro-pharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis J Gen Virol 67:2267–2272PubMedCrossRefGoogle Scholar
  7. Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Klein G (1986) Lymphoblastoid cell lines and Burkitt lymphoma derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen Int J Cancer 38: 729–737PubMedCrossRefGoogle Scholar
  8. Ernberg I, Danell E, Gratama JW, Oosterveer MAP, Klein, G (1989). Molecular weight variation of EBNAs as a mechanism to identify different Epstein-Barr virus isolates In Epstein-Barr virus and human disease II (Humana Press, Eds Ablashi) 341–347CrossRefGoogle Scholar
  9. Ernberg I (1988) Growth transformation of B lymphocytes by Epstein-Barr virus Cancer Rev 10:92–107Google Scholar
  10. Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masuc ci MG, Klein G (1989) The role of methylation in the pheno type dependent modulation of EBNA 2 and LMP genes in latently EBV infected cells J Gen Virol 70:2989–3002PubMedCrossRefGoogle Scholar
  11. Falk K, Ernberg I, Sakthivel R, Davis J, Christensson B, Luka J, Grierson H, Klein G, Purtilo D. Expression of Epstein-Barr virus encoded proteins and B-cell antigens in fatal infecttious mononucleosis Subm for publicationGoogle Scholar
  12. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T (1989) Epstein-Barr virus BZLF 1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos EMBO J 8:127–132PubMedGoogle Scholar
  13. Fåhraeus R, Fu Hu-Li, Ernberg I, Finke J, Rowe M, Klein, G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B (1988) Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma Int J Cancer 42:329–338PubMedCrossRefGoogle Scholar
  14. Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I (1988) Eradication of Epstein-Barr virus by allogeneic bone-marrow transplantation: Implications for sites of viral latency Proc Natl Acad Sci 85:8693–8696PubMedCrossRefGoogle Scholar
  15. Gratama JW, Oosterveer MAP, Lepoutre J, van Rood JJ, Zwaan FE, Vossen JMJJ, Kapsenberg JG, Klein G, Ernberg I (1989) Persistence and transfer of Epstein-Barr virus after allo geneic bone marrow transplantation Transplantation Proceedings 21:3097–3098PubMedGoogle Scholar
  16. Gratama J, Zutter MM, Minarovits J, Oosterveer MAP, Thomas ED, Klein G, Ernberg I. Expression of Epstein- Barr virus growth transformation-associated proteins in lymphoprolierative lesions of bone marrow transplant recipients Subm for publicationGoogle Scholar
  17. Greenspan JS, Greenspan D, Lennette ET, Abrahams DJ, Conant MA, Petersen V, Freese UK (1985) Replication of Esptein-Barr virus within the epothelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion N Engl J Med 313:1564–1571PubMedCrossRefGoogle Scholar
  18. Honess RW, Gompels UA, Barrell BG, Craxton M, Cameron KR, Staden R, Chang YN, Hayward GS (1989) Deviation from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes J Gen Virol 70:837–855PubMedCrossRefGoogle Scholar
  19. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin J (1974) Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx Proc Natl Acad Sci 71:4737–4741.PubMedCrossRefGoogle Scholar
  20. Klein G, Svedmyr E, Jondal M, Persson PO (1976) EBV-determined nuclear antigen (EBNA) positive cells in the peripheral blood of infectious mononucleosis patients Int J Cancer 17:21–26PubMedCrossRefGoogle Scholar
  21. Klein G (1989) Viral latency and transformation: the strategy of Epstein-Barr virus Cell 58:5–8PubMedCrossRefGoogle Scholar
  22. Li-Fu H, Minarovits J, Shi-Long C, Contreras-Salazar B, Rymo L, Falk K, Klein G, and Ernberg I.Hypomethylation of BNLF 1 5′-flanking region corelates to EBV-LMP (latent membrane protein) expression in nasopharyngeal carcinoma Subm for publicationGoogle Scholar
  23. Lewin N, Aman P, Masucci MG, Klein E, Klein G, öberg B, Strander H, Henle W, Henle G (1987) Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth Int J Cancer 39:472–476PubMedCrossRefGoogle Scholar
  24. Masucci MG, Contreras-Salazar B, Ragnar, E, Falk K, Minarovits J, Ernberg I, Klein G.(1989) 5-azacytidine up- regulates the expression of EBNA 2–6 and LMP in EBNA 1 positive, EBNA 2–6 and LMP-negative Burkitt lymphoma line J Virol 63: 3135–3141PubMedGoogle Scholar
  25. Minarovits J, Klein G, Ernberg I (subm for publication) EBV DNA methylation in Burkitt lymphoma tumor biopsies and derived cell linesGoogle Scholar
  26. Nilsson K (1971) High frequency-establishment of human immunoglo-bulin producing lymphoblastoid cell lines from normal and malignant tissue and peripheral blood Int J Cancer 8:432–42PubMedGoogle Scholar
  27. Nilsson K Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV Int J Cancer 8:443–450PubMedGoogle Scholar
  28. Ragona G, Sirianni M, Soddu S, Vercelli B, Piccoli M, Aiuti F (1986) Evidence for disregulation in the control of Epstein-Barr virus latency in patients with AIDS-related complex Clin Exp Immunol 66:17–24PubMedGoogle Scholar
  29. Rinaldo C, Kingsley L, Lyter DW, Rabin B, Atchison RW, Bodner AJ, Weiss SH, Saxinger WC (1986) Association of HTLV III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men J Infect Dis 154:556–561PubMedCrossRefGoogle Scholar
  30. Rickinson AB (1986) Cellular immunological responses to the virus infection. In “The Epstein-Barr virus” (Eds Esptein and Achong) William Heineman Med Books, London, p 75Google Scholar
  31. Robinson J, Smith D, Niederman J (1980) Mitotic EBNA positive lymphocytes in peripheral blood during infectious mononucleosis Nature 287:234–235Google Scholar
  32. Rowe DT, Rowe M, Evan G, Wallace LE, Farrel PJ, Rickinson AB (1986) Restricted expression of EBV latent genes and T lymphocyte detected membrane antigen in Burkitt’s lymphoma cells EMBO J 5:2599–2607PubMedGoogle Scholar
  33. Rowe M, Gregory C (1989) Epstein-Barr virus and Burkitt’s lymphoma In “Adv in Viral Oncology” (Ed G Klein), Raven Press, New York 8:237–259Google Scholar
  34. Sakthivel R, Christensson B, Ehlin-Henriksson B, Klein G (1989) Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin’s lymphomas Int J Cancer 43:624–630PubMedCrossRefGoogle Scholar
  35. Sixbey JW, Veserinen EH, Nedryd JG, Raab-Traub N, walton LA, Pagano JS (1983) Replication of Epstein-Barr virus in human epithelial cells infected in vitro Nature 306:480–483PubMedCrossRefGoogle Scholar
  36. Svedmyr ES, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G (1984) Virologic, immunologic and clinical observations on a patient during the incubation, acute and convalescent phases of infectious mononucleosis Clin Immunol Immunopathol 30:437–450.PubMedCrossRefGoogle Scholar
  37. Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the EBV-virus carrier state in healthy seropositive individuals Int J Cancer 35:35–42PubMedCrossRefGoogle Scholar
  38. Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989) Epstem-Barr virus-infected B cells persist in the circulation of acyclovir treated carriers Int J Cancer 43:67–71PubMedCrossRefGoogle Scholar
  39. Young L, Alfieri C, Hennessy K, Evans H, O’Hara C, Andersson KC, Ritz J, Shapiro RS, Rickinson AB, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation associated genes in tisuues of patients with EBV lymphoproliferative disease N Eng J Med 321:1080–1085CrossRefGoogle Scholar
  40. zur Hausen H; Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1970) EBV DNA in biopsies of Burkitts tumours and anaplastic carcinomas of the nasopahrynx Nature 228:1056–1058PubMedCrossRefGoogle Scholar
  41. Zutter MM, Martin PJ, Sale GE et al.(1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation Blood 72:520–529PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • I. Ernberg
    • 1
  1. 1.Department of Tumor BiologyKarolinska InstituteStockholmSweden

Personalised recommendations